Infectious Diseases (except HIV/AIDS)

  1. Statistical Properties of Stepped Wedge Cluster-Randomized Trials in Infectious Disease Outbreaks

    1. Lee Kennedy-Shaffer
    2. Marc Lipsitch

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19

    1. Sachin J. Shah
    2. Peter N. Barish
    3. Priya A. Prasad
    4. Amy Kistler
    5. Norma Neff
    6. Jack Kamm
    7. Lucy M. Li
    8. Charles Y. Chiu
    9. Jennifer M. Babik
    10. Margaret C. Fang
    11. Yumiko Abe-Jones
    12. Narges Alipanah
    13. Francisco N. Alvarez
    14. Olga Borisovna Botvinnik
    15. Gloria Castaneda
    16. Rand M. Dadasovich
    17. Jennifer Davis
    18. Xianding Deng
    19. Joseph L. DeRisi
    20. Angela M. Detweiler
    21. Scot Federman
    22. John Haliburton
    23. Samantha Hao
    24. Andrew D. Kerkhoff
    25. G. Renuka Kumar
    26. Katherine B. Malcolm
    27. Sabrina A. Mann
    28. Sandra Martinez
    29. Rupa Marya
    30. Eran Mick
    31. Lusajo Mwakibete
    32. Nader Najafi
    33. Michael J. Peluso
    34. Maira Phelps
    35. Angela Oliveira Pisco
    36. Kalani Ratnasiri
    37. Luis A. Rubio
    38. Anna Sellas
    39. Kyla D. Sherwood
    40. Jonathan Sheu
    41. Natasha Spottiswoode
    42. Michelle Tan
    43. Guixia Yu
    44. Kirsten Neudoerffer Kangelaris
    45. Charles Langelier

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Antibodies to SARS/CoV-2 in arbitrarily-selected Atlanta residents

    1. Jun Zou
    2. Alexis Bretin
    3. Andrew T. Gewirtz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Identification of IgG antibody response to SARS-CoV-2 spike protein and its receptor binding domain does not predict rapid recovery from COVID-19

    1. Kathleen M. McAndrews
    2. Dara P. Dowlatshahi
    3. Janine Hensel
    4. Luis L. Ostrosky-Zeichner
    5. Ramesh Papanna
    6. Valerie S. LeBleu
    7. Raghu Kalluri

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis

    1. Rajith K. R. Rajoli
    2. Henry Pertinez
    3. Usman Arshad
    4. Helen Box
    5. Lee Tatham
    6. Paul Curley
    7. Megan Neary
    8. Joanne Sharp
    9. Neill J. Liptrott
    10. Anthony Valentijn
    11. Christopher David
    12. Steven P. Rannard
    13. Ghaith Aljayyoussi
    14. Shaun H. Pennington
    15. Andrew Hill
    16. Marta Boffito
    17. Steve A. Ward
    18. Saye H. Khoo
    19. Patrick G. Bray
    20. Paul M. O'Neill
    21. W. David Hong
    22. Giancarlo A. Biagini
    23. Andrew Owen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Evaluating the efficiency of specimen pooling for PCR‐based detection of COVID‐19

    1. Supaporn Wacharapluesadee
    2. Thongchai Kaewpom
    3. Weenassarin Ampoot
    4. Siriporn Ghai
    5. Worrawat Khamhang
    6. Kanthita Worachotsueptrakun
    7. Phanni Wanthong
    8. Chatchai Nopvichai
    9. Thirawat Supharatpariyakorn
    10. Opass Putcharoen
    11. Leilani Paitoonpong
    12. Gompol Suwanpimolkul
    13. Watsamon Jantarabenjakul
    14. Pasin Hemachudha
    15. Artit Krichphiphat
    16. Rome Buathong
    17. Tanarak Plipat
    18. Thiravat Hemachudha

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2019

    1. Nicola Gaibazzi
    2. Chiara Martini
    3. Maria Mattioli
    4. Domenico Tuttolomondo
    5. Angela Guidorossi
    6. Sergio Suma
    7. Damini Dey
    8. Anselmo Palumbo
    9. Massimo De Filippo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2

    1. Nicholas M. Moore
    2. Haiying Li
    3. Debra Schejbal
    4. Jennifer Lindsley
    5. Mary K. Hayden

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Validation of a commercially available SARS-CoV-2 serological immunoassay

    1. B. Meyer
    2. G. Torriani
    3. S. Yerly
    4. L. Mazza
    5. A. Calame
    6. I. Arm-Vernez
    7. G. Zimmer
    8. T. Agoritsas
    9. J. Stirnemann
    10. H. Spechbach
    11. I. Guessous
    12. S. Stringhini
    13. J. Pugin
    14. P. Roux-Lombard
    15. L. Fontao
    16. C.-A. Siegrist
    17. I. Eckerle
    18. N. Vuilleumier
    19. L. Kaiser

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

    1. Silvia Stringhini
    2. Ania Wisniak
    3. Giovanni Piumatti
    4. Andrew S Azman
    5. Stephen A Lauer
    6. Hélène Baysson
    7. David De Ridder
    8. Dusan Petrovic
    9. Stephanie Schrempft
    10. Kailing Marcus
    11. Sabine Yerly
    12. Isabelle Arm Vernez
    13. Olivia Keiser
    14. Samia Hurst
    15. Klara M Posfay-Barbe
    16. Didier Trono
    17. Didier Pittet
    18. Laurent Gétaz
    19. François Chappuis
    20. Isabella Eckerle
    21. Nicolas Vuilleumier
    22. Benjamin Meyer
    23. Antoine Flahault
    24. Laurent Kaiser
    25. Idris Guessous

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 91 of 716 Next